Market Overview

AMAG Pharma Names Greg Madison Chief Commercial Officer

Related AMAG
AMAG Pharmaceuticals Responds to Recent Complete Response Letter From the FDA for the Single-Dose, Preservative-Free Vial of Makena(R)
Mid-Afternoon Market Update: Kirkland's Drops On Downbeat Earnings; Perry Ellis Shares Spike Higher

AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced the appointment of Greg Madison as executive vice president and chief commercial officer. Mr. Madison brings a wealth of hands-on commercial experience and extensive leadership skills to AMAG. He joins AMAG from Genzyme Corporation, where he spent the past 12 years in various commercial roles in their renal division, most recently as the division's vice president and general manager.

Posted-In: News Management


Related Articles (AMAG)

View Comments and Join the Discussion!

Get Benzinga's Newsletters